Centene (NYSE:CNC – Get Free Report) was upgraded by stock analysts at Argus from a “hold” rating to a “buy” rating in a research note issued on Tuesday, MarketBeat.com reports. Argus’ target price would indicate a potential upside of 20.28% from the company’s current price. Stifel Nicolaus set a $79.00 target price on shares of Centene in a research note on Monday, August 3rd. According to data from MarketBeat, Centene presently has an average rating of “Hold” and a consensus price target of $69.15. Centene Company Profile(Get Free Report)Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs.